Angelini Pharma secures exclusive option to license global development and commercialization rights for SVG1051, a pre-clinical investigational novel compound with broad potential to treat brain health diseases, excluding the Republic

FORT WASHINGTON, Pa., Sept. 22, 2025 (GLOBE NEWSWIRE) — Coventry, the leader and creator of the secondary market for life insurance, is proud to recognize Life Insurance Awareness Month by

Louis Cooper Chief Commercial Officer Axi ( CCO) Louis Cooper Chief Commercial Officer Axi ( CCO) SYDNEY, Sept. 22, 2025 (GLOBE NEWSWIRE) — Axi, a leading global online trading and

Governing Board approves major financing package as institution launches inaugural Euro benchmark bond OPEC Fund President Abdulhamid Alkhalifa OPEC Fund President Abdulhamid Alkhalifa VIENNA, Sept. 22, 2025 (GLOBE NEWSWIRE) —